Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Avita Medical Americas LLC is currently managing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This case is assigned to 1 distinct examiner, XU, QING, who is the busiest examiner with 1 pending application. The prosecution is limited to 1 distinct art unit, suggesting a specific technical application for the company's intellectual property.
The company's active portfolio consists of 1 pending office action, requiring a focused response to the 1 distinct examiner involved. Because XU, QING is the only examiner with a pending case, the company's current success in the Biotechnology & Pharmaceuticals sector depends on this single interaction. This 1 to 1 ratio of pending actions to examiners allows for a dedicated prosecution strategy.
Practitioners should focus on the 1 pending office action as the primary driver of the company's patent office activity. The involvement of 1 distinct art unit means that the examination will follow the specific standards and practices of that unit. Successfully navigating the 1 pending application under XU, QING is essential for the continued development of the company's patent portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| XU, QING | 1 | 50.9% | +55.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| Art Unit | Apps |
|---|---|
| 1656 | 1 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial